RecruitingNot ApplicableNCT01870752

Ovarian Tissue Transplantation

Autologous Orthotopic Transplantation of Previously Cryopreserved Ovarian Tissue

Sponsor

Abramson Cancer Center at Penn Medicine

Enrollment

10 participants

Start Date

Jun 1, 2013

Study Type

INTERVENTIONAL

Conditions

Infertile Females or Females With Ovarian Insufficiency

Summary

Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the efficacy and safety of autologous transplantation of previously cryopreserved ovarian cortical tissue in patients who experience infertility or ovarian insufficiency after cancer treatments.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Transplantation of previously cryopreserved ovarian tissu for people with infertile females or females with ovarian insufficiency. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETransplantation of previously cryopreserved ovarian tissu

Locations(1)

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01870752